Dr. Patterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
# Mayo
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pediatrics, 1992 - 1993
National Institute of Neurological Disorders and Stroke, Warren Grant Magnusson Clinical Center, National Institutes of HealthFellowship, Intramural Research, 1990 - 1992
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Child Neurology, 1988 - 1990- Royal Children's HospitalMedical Registrar, Pediatrics, 1988 - 1988
- University of QueenslandClinical Lecturer, Neurology, 1986 - 1987
- Royal Brisbane HospitalMedical Registrar, Internal Medicine, Nephrology, Hematology/Oncology, 1984 - 1985
- Royal Children's Hospital, Royal Brisbane HospitalInternship, 1982
- University of QueenslandMB BS, Medicine , First Class Honours, 1976 - 1981
The University of Queensland Medical SchoolClass of 1981
Certifications & Licensure
ND State Medical License 2014 - 2026
MN State Medical License 1990 - 2025
WI State Medical License 2013 - 2025
NY State Medical License 2000 - 2014- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors: New York Metro Area Castle Connolly, 2003-2007
- New York Magazine: Top Doctors Castle Connolly, 2002-2007
- Join now to see all
Clinical Trials
- Longitudinal Study of Cognition With Niemann-Pick Disease, Type C Start of enrollment: 2011 Mar 01
- Early Access Program With Arimoclomol in US Patients With NPC
Roles: Principal Investigator, Contact
- GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO) Start of enrollment: 2022 Feb 22
Roles: Contact
Publications & Presentations
PubMed
- 133 citationsA clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathiesSumit Parikh, Geneviève Bernard, Richard J. Leventer, Marjo S. van der Knaap, Johan L.K. Van Hove
Molecular Genetics and Metabolism. 2015-04-01 - 175 citationsCase Definition and Classification of Leukodystrophies and LeukoencephalopathiesAdeline Vanderver, Morgan Prust, Davide Tonduti, Fanny Mochel, Heather M. Hussey
Molecular Genetics and Metabolism. 2015-04-01 - 22 citationsChapter 174 – GangliosidosesMarc C. Patterson
Handbook of Clinical Neurology. 2013-12-31
Press Mentions
- Azafaros Receives FDA's IND Clearance and Fast Track Designation for Lead Asset AZ-3102January 5th, 2023
- What Is Niemann-Pick Disease Type C (NPC)?April 27th, 2022
- CytRx Comments on Orphazyme’s Promising 24-Month Interim Trial Results of Arimoclomol for Niemann-Pick Disease Type CJune 30th, 2021
- Join now to see all
Grant Support
- Training &EducationNational Institute Of Neurological Disorders And Stroke2009–2011
- Longitudinal Study Of Cognition In Subjects With Niemann-Pick Disease, Type CNational Institute Of Neurological Disorders And Stroke2009–2011
Committees
- Member, ABPN -Neurology Part C Examination Committee 2012 - 2018
- Member, Chair, ABPN - Neurodevelopmental Disabilities Recertification Committee 2001 - 2010
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
